The TRPV4 Agonist GSK1016790A Regulates the Membrane Expression of TRPV4 Channels

Sara Baratchi, Peter Keov, William Darby, +6

Frontiers in Pharmacology

Molecular Mechanisms of Bitopic Ligand Engagement with the M1 Muscarinic Acetylcholine Receptor

Peter Keov, Laura López, Shane M. Devine, +5

Journal of Biological Chemistry

Molecular Determinants of Allosteric Modulation at the M1 Muscarinic Acetylcholine Receptor

Alaa Abdul‐Ridha, Laura López, Peter Keov, +6

Journal of Biological Chemistry

AM833 Is a Novel Agonist of Calcitonin Family G Protein–Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective Agonists

Madeleine M. Fletcher, Peter Keov, Tin T. Truong, +8

Journal of Pharmacology and Experimental Therapeutics

Development of a human vasopressin V1a-receptor antagonist from an evolutionary-related insect neuropeptide

Maria Giulia Di Giglio, Markus Muttenthaler, Kasper Harpsøe, +11

Scientific Reports

Cyclotides Isolated from an Ipecac Root Extract Antagonize the Corticotropin Releasing Factor Type 1 Receptor

Mohsen Fahradpour, Peter Keov, Carlotta Tognola, +4

Frontiers in Pharmacology

Reverse Engineering of the Selective Agonist TBPB Unveils Both Orthosteric and Allosteric Modes of Action at the M1 Muscarinic Acetylcholine Receptor

Peter Keov, Céline Valant, Shane M. Devine, +4

Molecular Pharmacology

Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development

Sarah Arrowsmith, Peter Keov, Markus Muttenthaler, +1

Journal of Visualized Experiments

Nature-inspired dimerization as a strategy to modulate neuropeptide pharmacology exemplified with vasopressin and oxytocin

Zoltan Dekan, Thomas Kremsmayr, Peter Keov, +14

Chemical Science

Discovery of peptide probes to modulate oxytocin-type receptors of insects

Peter Keov, Zita Liutkevičiūtė, Roland Hellinger, +2

Scientific Reports